Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunization with virus-modified tumor cells

V Schirrmacher1, T Ahlert, T Pröbstle

  • 1Abteilung Zelluläre Immunologie (G0100), Deutsches Krebsforschungszentrum, Heidelberg, Germany.

Seminars in Oncology
|December 29, 1998
PubMed
Summary

Newcastle disease virus (NDV) offers an efficient, safe method for infecting tumor cells in gene therapy. This natural virus enhances cancer vaccines by stimulating immune responses and recruiting T-cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial Indoleamine-2,3-Dioxygenase-1 is not Critically Involved in Regulating Antitumor Immunity in the Central Nervous System.

International journal of tryptophan research : IJTR·2023
Same author

Isocitrate-dehydrogenase-mutant lower grade glioma in elderly patients: treatment and outcome in a molecularly characterized contemporary cohort.

Journal of neuro-oncology·2023
Same author

Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14.

Neuropathology and applied neurobiology·2019
Same author

Histone epiproteomic profiling distinguishes oligodendroglioma, IDH-mutant and 1p/19q co-deleted from IDH-mutant astrocytoma and reveals less tri-methylation of H3K27 in oligodendrogliomas.

Acta neuropathologica·2019
Same author

Integrated molecular characterization of IDH-mutant glioblastomas.

Neuropathology and applied neurobiology·2018
Same author

Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1.

Cell death and differentiation·2014

Area of Science:

  • Oncolytic virology
  • Immunotherapy
  • Gene therapy

Background:

  • Direct tumor cell infection for gene therapy vaccines faces limitations in efficiency, selectivity, and safety.
  • Newcastle disease virus (NDV), an avian paramyxovirus, possesses intrinsic immune-stimulating properties beneficial for cancer therapy.

Purpose of the Study:

  • To review the use of Newcastle disease virus (NDV) for efficient, selective, and safe infection of human tumor cells.
  • To highlight NDV's potential as an adjuvant in cancer vaccines by modulating immune responses.

Main Methods:

  • Utilizing NDV's natural cell-binding and selective cytoplasmic replication properties.
  • Exploring NDV's ability to induce T-cell costimulatory activity and prevent anergy.
  • Investigating NDV's capacity to recruit immune cells via chemokine and cytokine induction (RANTES, IP-10, IFN-α/β, TNF-α).

Related Experiment Videos

Main Results:

  • NDV demonstrates good cell-binding and selective replication in tumor cells, independent of proliferation.
  • NDV enhances anti-tumor immunity by promoting T-cell activation and recruitment.
  • Attachment of bispecific reagents via NDV's HN molecule offers further therapeutic potential.

Conclusions:

  • NDV presents a promising platform for oncolytic virotherapy and cancer vaccine development.
  • NDV's immunomodulatory effects make it a valuable adjuvant for enhancing cancer treatment strategies.
  • Clinical studies with autologous virus modified live cell vaccine (ATV)-NDV are ongoing.